Question-and-Answer Session
Operator
At this time I would like to remind everyone, in order to ask a question press "*" then the number "1" on your telephone keypad. We will pause for just a moment to compile the Q&A roster.
Your first question comes from Darren Lehrich with Deutsche Bank.
Darren Lehrich - Deutsche Bank
Thanks. Good morning, everyone. I do have a couple of questions here. I just want to start out with housekeeping one, Jamie. The hospital revenue and adjusted admission numbers for the Company in 2006 by quarter, if you could, excluding HMC, I think it would be good just to see how that lays out on a quarterly basis if you have that information?
Jamie Harris - Chief Financial Officer
Yeah, revenue would be $157.1 in the first quarter, $168.6 in the second quarter, $173.6 in the third quarter, $158.6 which is what we reported today in the fourth quarter.
Darren Lehrich - Deutsche Bank
Right.
Jamie Harris - Chief Financial Officer
I don't have the adjusted admissions at the moment, but I will get them for you later, before we end the call.
Darren Lehrich - Deutsche Bank
Okay, that's helpful. And then, the adjusted EBITDA in 2007 on a pro forma basis excluding HMC, just so we can look at the guidance that you just gave us, on a comparable basis?
Jamie Harris - Chief Financial Officer
Yeah, Darren, the net number is $99 million, I don't know, let me double check one thing. That number on a normalized, excluding Harlingen, it's going to be approximately $101.9 million.
Darren Lehrich - Deutsche Bank
Okay, great. That's helpful. And then so, Phil and Ed, heard your comments with regard to volume trends, maybe if you can just help us think about what you are looking for with regard to volume growth in 2008. I am not sure that I caught that, can you just give us a sense for what's embedded in your guidance for either adjusted admissions or admissions in what that growth rate looks like?
Ed French - President and Chief Executive Officer
Darren, good morning, it's Ed, and thanks for the question. We are expecting in '08, 3% to 4% adjusted admission growth, and as you heard us speak to this earlier, the industry had some general softness in the fourth quarter -- our fourth quarter -- third fiscal quarter from most of the others. And, also we saw that the drug-eluting stent conversions continue and we believe, as Phil and I both said, to trough.
- To read the full transcript on Seeking Alpha, click here »
